Evidence map›Paper›PMID 28806999›Full record

ArticleBMC medical research methodology2017

Trading certainty for speed - how much uncertainty are decisionmakers and guideline developers willing to accept when using rapid reviews: an international survey.

Gernot Wagner, Barbara Nussbaumer-Streit, Judith Greimel, Agustín Ciapponi, Gerald Gartlehner

Abstract read
In one paragraph

Article in BMC medical research methodology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Paper 2: Performing rapid reviews.Systematic reviews · 2022
    Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Improving reference prioritisation with PICO recognition.BMC medical informatics and decision making · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gernot WagnerDepartment for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Cochrane Austria, Dr. Karl Dorrek Strasse 30, 3500, Krems, Austria. gernot.wagner@donau-uni.ac.at.ORCID http://orcid.org/0000-0003-3626-3403
Barbara Nussbaumer-StreitDepartment for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Cochrane Austria, Dr. Karl Dorrek Strasse 30, 3500, Krems, Austria.
Judith GreimelUniversity Hohenheim, Schloss Hohenheim 1, 70599, Stuttgart, Germany.
Agustín CiapponiInstitute for Clinical Effectiveness and Health Policy, Dr. Emilio Ravignani 2024, C1414CPV, Buenos Aires, Argentina.
Gerald GartlehnerDepartment for Evidence-based Medicine and Clinical Epidemiology, Danube University Krems, Cochrane Austria, Dr. Karl Dorrek Strasse 30, 3500, Krems, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDecisionmakers and guideline developers demand rapid syntheses of the evidence when time sensitive evidence-informed decisions are required. A potential trade-off of such rapid reviews is that their results can have less reliability than results of systematic reviews that can lead to an increased risk of making incorrect decisions or recommendations. We sought to determine how much incremental uncertainty about the correctness of an answer guideline developers and health policy decisionmakers are willing to accept in exchange for a rapid evidence-synthesis.

methodsEmploying a purposive sample, we conducted an international web-based, anonymous survey of decisionmakers and guideline developers. Based on a clinical treatment, a public health, and a clinical prevention scenario, participants indicated the maximum risk of getting an incorrect answer from a rapid review that they would be willing to accept. We carefully reviewed data and performed descriptive statistical analyses.

resultsIn total, 325 (58.5%) of 556 participants completed our survey and were eligible for analysis. The median acceptable incremental risk for getting an incorrect answer from a rapid review across all three scenarios was 10.0% (interquartile range [IQR] 5.0-15.0). Acceptable risks were similar for the clinical treatment (n = 313, median 10.0% [IQR 5.0-15.0]) and the public health scenarios (n = 320, median 10.0% [IQR 5.0-15.0]) and lower for the clinical prevention scenario (n = 312, median 6.5% [IQR 5.0-10.5]).

conclusionsFindings suggest that decisionmakers are willing to accept some trade-off in validity in exchange for a rapid review. Nevertheless, they expect the validity of rapid reviews to come close to that of systematic reviews.

Indexed as

Evidence-Based MedicinePractice Guidelines as TopicReview Literature as TopicUncertaintyAdultAgedDecision MakingFemaleHumansMaleMiddle AgedReproducibility of ResultsSurveys and QuestionnairesYoung AdultDecisionmakerDecision-makingGuideline developerRapid reviewSystematic reviewUncertainty

Identifiers

PMID28806999
PMCPMC5557322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.